UX Contract › Industries › 541714
NAICS 541714
Research and Development in Biotechnology (except Nanobiotechnology): federal contracts
Who buys research and development in biotechnology (except nanobiotechnology) from the federal government, who wins the work, and where. Contract obligations in fiscal year 2026 (Oct 1, 2025 to Sep 30, 2026), from USAspending.gov. Contract award types A to D (BPA calls, purchase orders, delivery orders and definitive contracts). Obligations can be negative when an agency takes money back. Data saved from USAspending.gov on Oct 23, 2026.
$2.10 billion$2,104,177,920 in contract obligations
1,100contract awards with money in the year
10agencies buying (top 10 shown)
15states with work
Agencies buying
- 1. Department of Health and Human Services$1.68 billion · 79.7%
- 2. Department of Defense$355.7 million · 16.9%
- 3. Department of Veterans Affairs$33.5 million · 1.6%
- 4. National Aeronautics and Space Administration$22.3 million · 1.1%
- 5. Department of the Interior$9.8 million · 0.5%
- 6. Department of Homeland Security$2.8 million · 0.1%
- 7. Department of Agriculture$2.2 million · 0.1%
- 8. Environmental Protection Agency$483,452 · 0.0%
- 9. Smithsonian Institution$71,530 · 0.0%
- 10. Department of Justice$17,411 · 0.0%
Top companies (recipients)
- 1. ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)$266.2 million · 12.7%
- 2. SHIONOGI INC$156.1 million · 7.4%
- 3. ADVANCED TECHNOLOGY INTERNATIONAL$154.0 million · 7.3%
- 4. AMGEN USA INC$126.0 million · 6.0%
- 5. L3 TECHNOLOGIES, INC.$117.5 million · 5.6%
- 6. KALEO, INC.$99.8 million · 4.7%
- 7. START2 GROUP, INC.$89.1 million · 4.2%
- 8. MAPP BIOPHARMACEUTICAL, INC.$83.1 million · 3.9%
- 9. BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL$54.9 million · 2.6%
- 10. OSSIUM HEALTH, INC.$48.9 million · 2.3%
Where the work is (states)
- 1. California$364.3 million · 17.3%
- 2. Massachusetts$270.6 million · 12.9%
- 3. District Of Columbia$268.8 million · 12.8%
- 4. New Jersey$191.2 million · 9.1%
- 5. South Carolina$162.1 million · 7.7%
- 6. Virginia$154.3 million · 7.3%
- 7. Maryland$143.9 million · 6.8%
- 8. Utah$120.7 million · 5.7%
- 9. Texas$68.6 million · 3.3%
- 10. North Carolina$57.2 million · 2.7%
Largest awards in NAICS 541714
| Recipient | Amount | Agency | What | Dates | Award |
|---|---|---|---|---|---|
| THE BOEING COMPANY AL | $4.44 billion $4,442,892,884 | Department of Defense Missile Defense Agency | GBI/AUR PROGRAM MANAGEMENT/SYSTEMS ENG NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Mar 18, 2019 to Mar 31, 2029 | HQ014719C0004 ↗ |
| ADVANCED TECHNOLOGY INTERNATIONAL SC | $1.01 billion $1,010,801,807 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | OT TASK ORDER 4 NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Sep 29, 2023 to Dec 31, 2030 | 75A50123F61004 ↗ |
| AMGEN USA INC CA | $839.9 million $839,875,190 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Sep 30, 2022 to Sep 29, 2032 | 75A50122C00065 ↗ |
| ADVANCED TECHNOLOGY INTERNATIONAL SC | $795.0 million $795,000,000 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | OTA TASK ORDER 1 NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Sep 28, 2023 to Dec 31, 2029 | 75A50123F61001 ↗ |
| ADVANCED TECHNOLOGY INTERNATIONAL SC | $723.5 million $723,524,000 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | OT TASK ORDER 3 NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Sep 29, 2023 to Dec 31, 2030 | 75A50123F61003 ↗ |
| SIGA TECHNOLOGIES, INC. OR | $626.5 million $626,506,870 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Sep 10, 2018 to Aug 30, 2029 | 75A50118C00019 ↗ |
| ADVANCED TECHNOLOGY INTERNATIONAL SC | $563.7 million $563,743,254 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | OT TASK ORDER 8-RAPID PANDEMIC INFLUENZA AND EMERGING INFECTIOUS DISEASE VACCINE DEVELOPMENT AND RESPONSE CAPABILITY NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Jun 14, 2024 to Sep 30, 2036 | 75A50124F61008 ↗ |
| ALLUCENT GOVERNMENT SERVICES (US) LLC TX | $370.1 million $370,059,439 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Aug 22, 2023 to Apr 11, 2025 | 75A50123F33005 ↗ |
| ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. OH | $330.2 million $330,226,484 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Aug 22, 2023 to Apr 11, 2025 | 75A50123F33006 ↗ |
| TECHNICAL RESOURCES INTERNATIONAL, INC. MD | $317.1 million $317,148,294 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION NAICS 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | Aug 22, 2023 to Aug 21, 2028 | 75A50123F33004 ↗ |